Unexpected developments in immune organs in WHIM syndrome

Blood

Volumn 119, Issue 24, 2012, Pages 5610-5612

  Murphy, Philip M ^a   McDermott, David H ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; PLERIXAFOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; B LYMPHOCYTE; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COMPARTMENTALIZATION; DRUG EFFICACY; DRUG SAFETY; GAIN OF FUNCTION MUTATION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; IMMUNE DEFICIENCY; LEUKOCYTE; LYMPHOID CELL; MYELOPOIESIS; NEUTROPENIA; NEUTROPHIL COUNT; NONHUMAN; NOTE; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RECEPTOR GENE; WHIM SYNDROME;

EID: 84862488184     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-04-420752     Document Type: Note

References (11)

1. Balabanian K, Brotin E, Biajoux V, et al. Proper desensitization of CXCR4 is required for lymphocyte development and peripheral compartmentalization in mice. Blood. 2012;119(24):5722-5730.
2. Kawai T, Malech HL. WHIM syndrome: congenital immune deficiency disease. Curr Opin Hematol. 2009;16(24):20-26.
3. Hernandez PA, Gorlin RJ, Lukens JN, et al. Mutations in the chemokine receptor gene CXCR4 are associated with WHIMsyndrome, a combined immunodeficiency disease. Nat Genet. 2003;34(1):70-74. (Pubitemid 36548793)
4. Eash KJ, Greenbaum AM, Gopalan PK, Link DC. CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow. J Clin Invest. 2010;20(7):2423-2431.
5. Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature. 1998;393(6685):595-599. (Pubitemid 28319251)
6. Mc Guire PJ, Cunningham-Rundles C, Ochs H, Diaz GA. Oligoclonality, impaired class switch and B-cell memory responses in WHIM syndrome. Clin Immunol. 2010;135(3):412-421.
7. Dale DC, Bolyard AA, Kelley ML, et al. The CXCR4 antagonist plerixafor is a potential therapy for myelokathexis, WHIM syndrome. Blood. 2011;118(18):4963-4966.
8. McDermott DH, Liu Q, Ulrick J, et al. The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome. Blood. 2011;118(18):4957-4962.
9. Kawai T, Choi U, Cardwell L, et al. WHIM syndrome myelokathexis reproduced in the NOD/SCID mouse xenotransplant model engrafted with healthy human stem cells transduced with Cterminus-truncated CXCR4. Blood. 2007;109(1):78-84. (Pubitemid 46070121)
10. Walters KB, Green JM, Surfus JC, Yoo SK, Huttenlocher A. Live imaging of neutrophil motility in a zebrafish model of WHIM syndrome. Blood. 2010;116(15):2803-2811.
11. Chow KY, Brotin E, Ben Khalifa Y, et al. A pivotal role for CXCL12 signaling in HPV-mediated transformation of keratinocytes: clues to understanding HPV-pathogenesis in WHIM syndrome. Cell Host Microbe. 2010;8(6):523-533.